Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) ...

There may still be scarring on the liver, but it has not progressed enough ... Treatments include medications, lifestyle changes, and surgery. Depending on the cause of cirrhosis, your doctor ...

Akero reported Monday strong results showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused ...

Hepatic fibrosis is a reversible wound healing response characterized by accumulation of extracellular matrix (ECM), or "scar," that follows chronic but not self-limited liver disease. The ECM ...

The experimental drug efruxifermin is being studied in patients with severe scarring or cirrhosis due to a type of fatty liver disease known as metabolic dysfunction-associated steatohepatitis (MASH).

A Cleveland Clinic study reveals that bariatric surgery significantly reduces the risk of serious liver complications in ...

Kelly Rasmussen, Carbon County community member, was diagnosed with Primary Sclerosing Cholangitis (PSC) about 15 years ago, ...

Removing 10 per cent of a patient’s blood before major liver surgery and giving it back afterwards reduced transfusions by half, according to a large clinical trial published in The Lancet ...

VCU has announced the Health Hume-Lee Transplant Center is the first in the world to use robotic surgery that improves the ...

After 96 weeks, 39% of patients offered a 50-mg dose of efruxifermin showed a clinically meaningful reduction in liver fibrosis, or scarring, without other symptoms of MASH getting worse, compared ...